Solubility based Biowaiver [Dissolution / BCS / IVIVC]

posted by Amalia – Greece, 2018-10-02 10:59 (2467 d 04:40 ago) – Posting: # 19360
Views: 7,226

Dear Obinoscopy,

what I guess I should have clarified is that the reason we are trying to use this justification is because the lower strength is not proportional in terms of excipients.

❝ The advise was given by an "external clinical expert".


I presume this is why we were advised to follow the solubility path for a biowaiver? That is why we are wondering whether we should perform the solubility tests at the API or the final formulation.
What do you think?

Kind Regards,

Amalia

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,678 registered users;
84 visitors (0 registered, 84 guests [including 54 identified bots]).
Forum time: 15:39 CEST (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5